MRO Explained: The Person Standing Between Your Driver and a Wrongful Positive

A Medical Review Officer (MRO) is a licensed physician who reviews certain DOT drug-testing results before they become official. For drivers and fleet managers, the MRO serves as an independent checkpoint between the laboratory report and the employer’s final result. That review helps protect the integrity of the testing program while ensuring that a legitimate prescription or medical explanation is not mistaken for a DOT violation.

If you have ever wondered, “What does a Medical Review Officer do in DOT testing?”, the short answer is this: the MRO examines the laboratory findings, checks the documentation, speaks with the driver when required, evaluates possible medical explanations, and reports the verified outcome through the proper channels. Under 49 CFR Part 40, Subpart G, the MRO must act as an independent and impartial gatekeeper for the accuracy, confidentiality, and fairness of the drug-testing process.

WHAT IS A MEDICAL REVIEW OFFICER?

A DOT MRO is not simply an administrator who forwards laboratory results. The MRO must be a licensed physician with specialized knowledge of controlled-substance disorders, alternative medical explanations for test results, specimen adulteration and substitution, chain-of-custody requirements, and applicable DOT regulations. The physician must also complete required qualification training and pass an examination through a nationally recognized certification board, with requalification required during each five-year period.

The MRO’s role is separate from the employer’s role. The MRO does not decide whether a driver is generally fit for duty, and the MRO does not replace the Designated Employer Representative (DER), Substance Abuse Professional (SAP), laboratory, or collection site. Instead, the MRO reviews the medical and regulatory meaning of the laboratory result before the employer receives the official verified determination.

According to the U.S. Department of Transportation’s MRO guidance, the physician must determine whether there is a legitimate medical explanation for certain confirmed positive, adulterated, substituted, or invalid results. The MRO must also ensure the timely flow of information and protect confidential drug-testing records.

Quick Tip: A laboratory result and an MRO-verified result are not always the same thing. Do not treat a non-negative laboratory report as a final DOT violation until the MRO completes the verification process.

HOW THE MRO REVIEW PROCESS WORKS

When a laboratory reports a confirmed non-negative result, the MRO begins an administrative and medical review. The physician examines the Federal Custody and Control Form, confirms that the documentation is consistent and legible, and checks for errors that could require the test to be cancelled. The MRO then conducts a confidential verification interview with the driver unless a specific regulatory exception allows the result to be verified without an interview.

During the interview, the driver has an opportunity to explain the result. The MRO may ask about prescribed medications, medical treatment, or other information that could provide a legitimate medical explanation, but the driver must respond promptly and honestly. Under 49 CFR § 40.131, the MRO must make reasonable efforts to contact the employee, and failing to communicate can affect how the result is verified.

The MRO may ultimately classify the test as:

• Verified negative
• Verified positive
• Cancelled
• Refusal to test because of adulteration or substitution
• Another result category permitted under DOT regulations

The key point is that the MRO: not the collection site, employer, or driver: makes the final verification decision for the laboratory result. The FMCSA explains that MROs review laboratory results, evaluate legitimate medical explanations, and report verified results to the DER in a timely and confidential manner.

LAB POSITIVE VS. MRO-VERIFIED POSITIVE

A laboratory positive means the laboratory detected a drug or metabolite at or above the applicable testing cutoff after its analysis and confirmation procedures. That finding starts the MRO review, but it does not automatically mean the driver has a reportable DOT violation. The MRO must first determine whether the result is supported by the documentation and whether the driver has an acceptable medical explanation.

An MRO-verified positive is the final determination after the physician completes the required review. If the driver provides a legitimate and acceptable explanation, the MRO does not verify the test as positive. If the explanation is not acceptable: or if the driver does not provide the requested information: the MRO may verify the test as positive, adulterated, substituted, or another applicable result.

This distinction is one of the most important protections in DOT drug testing. It prevents an initial laboratory finding from being treated as conclusive when a lawful prescription or testing-process issue may explain the result. At the same time, it preserves safety by requiring the MRO to verify a positive when the available facts do not support a legitimate explanation.

HOW PRESCRIPTION MEDICATIONS ARE HANDLED

A prescription may explain why a particular substance appeared in a driver’s specimen, but simply having a prescription does not guarantee that the result will be changed. The MRO evaluates whether the medication could reasonably account for the laboratory finding and whether the driver used the medication in a manner consistent with the prescription. The physician may request documentation or communicate with the prescribing practitioner when necessary.

If the explanation is valid and acceptable, the MRO generally verifies the result as negative or cancels it, depending on the circumstances. The employer receives the verified outcome: not unnecessary details about the driver’s private medical history: and the result is not treated as a verified positive DOT violation. If the prescription cannot be verified, does not explain the result, or indicates misuse, the MRO may verify the result as positive.

Drivers should keep accurate medication information available and respond quickly if the MRO requests an interview. Fleet managers should also avoid asking drivers to disclose medical details to supervisors or coworkers; the MRO process exists specifically to handle sensitive information through the appropriate confidential channel.

Quick Tip: If you receive a call or message from an MRO, contact the physician promptly and have relevant prescription information ready. Do not assume that ignoring the call will make the issue disappear.

WHAT HAPPENS AFTER A VERIFIED POSITIVE?

After completing the review, the MRO reports the verified result to the DER or, when authorized by the employer, through its C/TPA. The report must be confidential and must identify the applicable result category, such as positive, negative, cancelled, or refusal. The MRO does not provide quantitative drug-test values to the DER or C/TPA under the standard reporting requirements.

For an FMCSA-regulated CDL driver, a verified positive drug test, verified adulterated or substituted result, or applicable refusal must also be reported to the FMCSA Drug & Alcohol Clearinghouse. Under 49 CFR § 382.705, the MRO generally must report the qualifying violation within two business days of making the determination or verification. A later change to a verified result also has reporting requirements.

A legitimate prescription explanation that results in a verified negative does not create a positive Clearinghouse violation. However, a verified positive can place the driver in a prohibited status and trigger the DOT return-to-duty process, including an evaluation by a qualified SAP and required follow-up testing. That is why accurate MRO communication and timely Clearinghouse management matter to both the driver and the carrier.

THE DRIVER’S SPLIT-SPECIMEN RIGHT

When an MRO verifies a drug test as positive: or determines a refusal because of adulteration or substitution: the driver must be informed of the right to request testing of the split specimen. The split specimen is the second portion of the original specimen that can be sent to another qualified laboratory for testing.

Under 49 CFR § 40.153, the driver generally has 72 hours from notification to request the split-specimen test. The request must be made to the MRO, and the employer must ensure the test is conducted when the request is timely; the driver is not required to pay the testing cost before it takes place, although the employer may seek reimbursement afterward.

This right is time-sensitive, so drivers should act immediately if they disagree with a verified result. Labworks USA lists donor-requested split-specimen testing at $400, although the exact arrangements and applicable charges should be confirmed with the MRO or compliance provider handling the case.

WHAT FLEET MANAGERS SHOULD DO

Your responsibility is not to interpret medical information or conduct your own investigation into a driver’s prescription history. Your responsibility is to maintain accurate driver contact information, designate the appropriate DER, protect confidentiality, follow the MRO’s instructions, and take required action after receiving the official verified result. You should also maintain organized records so your program can withstand an audit or inspection.

Use this practical checklist:

• Keep the driver’s current phone numbers and contact information on file.
• Make sure your DER knows how to respond to an MRO contact request.
• Do not circulate non-negative laboratory results before the MRO completes verification.
• Record the date and time of MRO and driver communications.
• Follow any required removal-from-duty, SAP, return-to-duty, or follow-up procedures.
• Confirm that qualifying violations are reported to the Clearinghouse.
• Conduct required pre-employment and annual Clearinghouse queries.
• Store records securely and limit access to authorized personnel.

The convenient and practical solution is to use a qualified C/TPA to coordinate testing, MRO communication, reporting, and documentation. Labworks USA can help manage FMCSA Clearinghouse responsibilities, including pre-employment and annual queries, violation reporting, and return-to-duty information.

HOW LABWORKS USA CAN HELP

Labworks USA provides compliance support for owner-operators and carriers that need a reliable DOT drug and alcohol testing program. Through our consortium membership and testing network, you can access collection services, MRO review, electronic Chain of Custody Forms, reporting support, and assistance with Clearinghouse responsibilities. Our goal is to handle the administrative details so you can focus on safe operations and keeping your drivers moving.

A DOT Drug and Alcohol Testing Consortium Annual Membership is $49.95 for one full year, and membership takes effect immediately after registration. Additional services are available when needed, including DOT random drug tests listed at $82, pre-employment tests at $83, and FMCSA Clearinghouse query management at $21 per driver per year. If you need one-on-one help with an initial Clearinghouse registration or an existing account, registration assistance is listed at $210.

You can review Labworks USA rates, learn about additional services, or contact our team to discuss your compliance needs. If a driver has a confirmed issue, do not delay; timely communication with the MRO and your C/TPA can help prevent missed deadlines and avoidable administrative problems.

IN CONCLUSION

The Medical Review Officer is the critical decision point between a laboratory finding and a final DOT drug-test result. By reviewing the laboratory documentation, interviewing the driver, evaluating prescriptions and medical explanations, and reporting only verified outcomes, the MRO helps protect both public safety and due process. The result is a testing system that takes violations seriously without treating every initial non-negative finding as an automatic positive.

Regulations, Clearinghouse procedures, and agency guidance can change, so your compliance program must be kept current. Drivers should respond quickly to MRO communications, and fleet managers should maintain accurate records, clear DER procedures, and reliable reporting support. With Labworks USA as your C/TPA partner, you can make MRO coordination and broader DOT compliance more convenient and manageable.

INDUSTRY KEYWORDS AND RESOURCES

Use these search terms when researching the subject further:

• Medical Review Officer MRO
• What does a Medical Review Officer do in DOT testing
• DOT MRO verification process
• MRO prescription explanation
• MRO-verified positive vs. laboratory positive
• DOT split specimen request
• 72-hour split-specimen rule
• FMCSA Clearinghouse violation reporting
• 49 CFR Part 40 Subpart G
• DOT drug-testing prescription medications
• Designated Employer Representative MRO process
• FMCSA return-to-duty process

For the controlling requirements, review the DOT Medical Review Officer guidance, FMCSA MRO overview, and the official 49 CFR Part 40 regulations.